Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Health Catalyst, Inc.HCAT · Entity 1565 | Director · Chief Executive Officer | September 14, 2026 | September 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Health Catalyst, Inc.
Report date September 14, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,856,385 |
Ending reported balance
After 2026-09-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-14 · Grant · Acquired 2,747,385 · Balance 2,797,385 F1: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2026 Employment Inducement Incentive Plan (the "2026 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2026 Plan, 915,975 RSUs will vest on September 4, 2027 and, thereafter, the remaining RSUs will vest in 8 approximately equal quarterly installments. Row 2 · 2026-09-14 · Purchase · Acquired 59,000 · Balance 2,856,385 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2026 Employment Inducement Incentive Plan (the "2026 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2026 Plan, 915,975 RSUs will vest on September 4, 2027 and, thereafter, the remaining RSUs will vest in 8 approximately equal quarterly installments.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Performant Healthcare Inc
Report date October 21, 2025 · Filed October 21, 2025
Section 16 reporting ended · disclosed 2025-10-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-10-21 transaction · row 1
1 source rowRow 1 · 2025-10-21 · Disposition to issuer · Disposed 619,309 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated July 31, 2025 (the "Merger Agreement"), by and among Performant Healthcare, Inc. ("Performant" or "Company"), Continental Buyer, Inc., a Delaware corporation ("Continental" or "Parent") and Prevail Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Continental ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Performant, with Performant surviving the merger as a wholly-owned subsidiary of Continental (the "Merger"). F2: Effective as of immediately prior to the Effective Time (as defined in the Merger Agreement), each share of the Company's Common Stock, par value $0.0001 per share, as the "Common Stock" or "Company Shares" issued and outstanding immediately prior to the Effective Time was canceled and converted into the right to receive $7.75 in cash without interest (the "Merger Consideration") subject to any applicable withholding taxes as provided in the Merger Agreement. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2025-10-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-10-21 · Disposition to issuer · Disposed 25,000 · Balance 0 F3: Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to time-based vesting restrictions, whether vested or unvested, that is outstanding immediately prior to the Effective Time (each, a "Performant RSU") will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (i) the total number of Company Shares underlying such Performant RSU multiplied by (ii) the Merger Consideration. F4: All equity awards under the terms of the Company's Amended and Restated 2012 Stock Incentive Plan expire on the tenth anniversary of the original grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2025-10-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-10-21 · Disposition to issuer · Disposed 41,538 · Balance 0 F3: Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to time-based vesting restrictions, whether vested or unvested, that is outstanding immediately prior to the Effective Time (each, a "Performant RSU") will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (i) the total number of Company Shares underlying such Performant RSU multiplied by (ii) the Merger Consideration. F4: All equity awards under the terms of the Company's Amended and Restated 2012 Stock Incentive Plan expire on the tenth anniversary of the original grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2025-10-21 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-10-21 · Disposition to issuer · Disposed 91,724 · Balance 0 F3: Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to time-based vesting restrictions, whether vested or unvested, that is outstanding immediately prior to the Effective Time (each, a "Performant RSU") will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (i) the total number of Company Shares underlying such Performant RSU multiplied by (ii) the Merger Consideration. F4: All equity awards under the terms of the Company's Amended and Restated 2012 Stock Incentive Plan expire on the tenth anniversary of the original grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2025-10-21 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-10-21 · Disposition to issuer · Disposed 91,724 · Balance 0 F5: Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to performance-based vesting conditions, that is outstanding immediately prior to the Effective Time (each, a "Performant PRSU") (i) to the extent not vested, shall be deemed to have satisfied such vesting conditions at 100% of target and shall have any time-based vesting conditions waived and (ii) will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (A) the number of Company Shares underlying such Performant PRSU multiplied by (B) the Merger Consideration. F4: All equity awards under the terms of the Company's Amended and Restated 2012 Stock Incentive Plan expire on the tenth anniversary of the original grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2025-10-21 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-10-21 · Disposition to issuer · Disposed 118,419 · Balance 0 F3: Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to time-based vesting restrictions, whether vested or unvested, that is outstanding immediately prior to the Effective Time (each, a "Performant RSU") will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (i) the total number of Company Shares underlying such Performant RSU multiplied by (ii) the Merger Consideration. F4: All equity awards under the terms of the Company's Amended and Restated 2012 Stock Incentive Plan expire on the tenth anniversary of the original grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2025-10-21 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2025-10-21 · Disposition to issuer · Disposed 105,789 · Balance 0 F5: Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to performance-based vesting conditions, that is outstanding immediately prior to the Effective Time (each, a "Performant PRSU") (i) to the extent not vested, shall be deemed to have satisfied such vesting conditions at 100% of target and shall have any time-based vesting conditions waived and (ii) will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (A) the number of Company Shares underlying such Performant PRSU multiplied by (B) the Merger Consideration. F4: All equity awards under the terms of the Company's Amended and Restated 2012 Stock Incentive Plan expire on the tenth anniversary of the original grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2025-10-21 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2025-10-21 · Disposition to issuer · Disposed 198,320 · Balance 0 F3: Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to time-based vesting restrictions, whether vested or unvested, that is outstanding immediately prior to the Effective Time (each, a "Performant RSU") will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (i) the total number of Company Shares underlying such Performant RSU multiplied by (ii) the Merger Consideration. F4: All equity awards under the terms of the Company's Amended and Restated 2012 Stock Incentive Plan expire on the tenth anniversary of the original grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2025-10-21 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2025-10-21 · Disposition to issuer · Disposed 198,319 · Balance 0 F5: Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to performance-based vesting conditions, that is outstanding immediately prior to the Effective Time (each, a "Performant PRSU") (i) to the extent not vested, shall be deemed to have satisfied such vesting conditions at 100% of target and shall have any time-based vesting conditions waived and (ii) will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (A) the number of Company Shares underlying such Performant PRSU multiplied by (B) the Merger Consideration. F4: All equity awards under the terms of the Company's Amended and Restated 2012 Stock Incentive Plan expire on the tenth anniversary of the original grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated July 31, 2025 (the "Merger Agreement"), by and among Performant Healthcare, Inc. ("Performant" or "Company"), Continental Buyer, Inc., a Delaware corporation ("Continental" or "Parent") and Prevail Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Continental ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Performant, with Performant surviving the merger as a wholly-owned subsidiary of Continental (the "Merger").
F2: Effective as of immediately prior to the Effective Time (as defined in the Merger Agreement), each share of the Company's Common Stock, par value $0.0001 per share, as the "Common Stock" or "Company Shares" issued and outstanding immediately prior to the Effective Time was canceled and converted into the right to receive $7.75 in cash without interest (the "Merger Consideration") subject to any applicable withholding taxes as provided in the Merger Agreement.
F3: Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to time-based vesting restrictions, whether vested or unvested, that is outstanding immediately prior to the Effective Time (each, a "Performant RSU") will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (i) the total number of Company Shares underlying such Performant RSU multiplied by (ii) the Merger Consideration.
F4: All equity awards under the terms of the Company's Amended and Restated 2012 Stock Incentive Plan expire on the tenth anniversary of the original grant date.
F5: Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to performance-based vesting conditions, that is outstanding immediately prior to the Effective Time (each, a "Performant PRSU") (i) to the extent not vested, shall be deemed to have satisfied such vesting conditions at 100% of target and shall have any time-based vesting conditions waived and (ii) will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (A) the number of Company Shares underlying such Performant PRSU multiplied by (B) the Merger Consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 13, 2020 Filed May 15, 2020 21:43 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Tax withholdingCommon Stock, par value $0.0001 per share | 4,424 | $0.70 | $3,114.50 |
DisclosureSEC source: 0001550695-20-000039 · wf-form4_158959335636884.xml · nonDerivative · entry 2 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,907 F1 · shares: Shares surrendered to pay tax liability due on vesting of Restricted Stock Units Read SEC document |
| May 13, 2020 Filed May 15, 2020 21:43 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Exercise / conversionCommon Stock, par value $0.0001 per share | 18,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001550695-20-000039 · wf-form4_158959335636884.xml · nonDerivative · entry 1 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:51 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Exercise / conversionRestricted Stock Units · Derivative | 11,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001550695-20-000027 · wf-form4_158838068470271.xml · derivative · entry 3 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,750 Underlying: Common Stock · 11,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to the Reporting Person. F2 · price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to the Reporting Person. F3 · derivative.exercise_date: Restricted Stock Unit award was granted on May 2, 2019. 25% of the shares vested on April 29, 2020, with 25% more vesting on the second, third and fourth anniversaries of April 29, 2019, provided that the Reporting Person remains in continuous service through each vest date. F3 · derivative.expiration_date: Restricted Stock Unit award was granted on May 2, 2019. 25% of the shares vested on April 29, 2020, with 25% more vesting on the second, third and fourth anniversaries of April 29, 2019, provided that the Reporting Person remains in continuous service through each vest date. Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:51 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Tax withholdingCommon Stock, par value $0.0001 per share | 3,336 | $0.72 | $2,401.92 |
DisclosureSEC source: 0001550695-20-000027 · wf-form4_158838068470271.xml · nonDerivative · entry 2 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,581 F1 · shares: Shares surrendered to pay tax liability due on vesting of Restricted Stock Units Read SEC document |
| April 29, 2020 Filed May 1, 2020 20:51 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Exercise / conversionCommon Stock, par value $0.0001 per share | 11,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001550695-20-000027 · wf-form4_158838068470271.xml · nonDerivative · entry 1 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,917 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2020 Filed Mar 10, 2020 21:51 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Exercise / conversionRestricted Stock Units · Derivative | 11,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001550695-20-000011 · wf-form4_158389145450276.xml · derivative · entry 3 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to the Reporting Person. F2 · price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to the Reporting Person. F3 · derivative.exercise_date: Restricted Stock Unit award was granted on 02/22/16. 25% of the shares vested on March 7, 2017, 25% of the shares vested on March 7, 2018, 25% of the shares vested on March 7, 2019, and 25% of the shares vested on March 7, 2020. F3 · derivative.expiration_date: Restricted Stock Unit award was granted on 02/22/16. 25% of the shares vested on March 7, 2017, 25% of the shares vested on March 7, 2018, 25% of the shares vested on March 7, 2019, and 25% of the shares vested on March 7, 2020. Read SEC document |
| March 07, 2020 Filed Mar 10, 2020 21:51 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Tax withholdingCommon Stock, par value $0.0001 per share | 3,336 | $0.97 | $3,232.58 |
DisclosureSEC source: 0001550695-20-000011 · wf-form4_158389145450276.xml · nonDerivative · entry 2 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,667 F1 · shares: Shares surrendered to pay tax liability due on vesting of Restricted Stock Units Read SEC document |
| March 07, 2020 Filed Mar 10, 2020 21:51 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Exercise / conversionCommon Stock, par value $0.0001 per share | 11,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001550695-20-000011 · wf-form4_158389145450276.xml · nonDerivative · entry 1 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,003 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2019 Filed May 14, 2019 19:51 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Exercise / conversionRestricted Stock Units · Derivative | 14,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001550695-19-000042 · wf-form4_155787786917774.xml · derivative · entry 6 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,125 Underlying: Common Stock · 14,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to the Reporting Person. F2 · price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to the Reporting Person. F4 · derivative.exercise_date: Restricted Stock Unit award was granted on March 29, 2018. 25% of the shares vested on May 10, 2019, with 25% more vesting on the first day of the next open trading window immediately following each of the second, third and fourth anniversaries of the grant date, provided that the Reporting Person remains in continuous service through each vest date. F4 · derivative.expiration_date: Restricted Stock Unit award was granted on March 29, 2018. 25% of the shares vested on May 10, 2019, with 25% more vesting on the first day of the next open trading window immediately following each of the second, third and fourth anniversaries of the grant date, provided that the Reporting Person remains in continuous service through each vest date. F4 · balance_after: Restricted Stock Unit award was granted on March 29, 2018. 25% of the shares vested on May 10, 2019, with 25% more vesting on the first day of the next open trading window immediately following each of the second, third and fourth anniversaries of the grant date, provided that the Reporting Person remains in continuous service through each vest date. Read SEC document |
| May 10, 2019 Filed May 14, 2019 19:51 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Exercise / conversionRestricted Stock Units · Derivative | 18,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001550695-19-000042 · wf-form4_155787786917774.xml · derivative · entry 5 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 18,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to the Reporting Person. F2 · price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to the Reporting Person. F3 · derivative.exercise_date: Restricted Stock Unit award was granted on April 6, 2017. 25% of the shares vested on May 11, 2018, 25% of the shares vested on May 10, 2019, with 25% more vesting on the first day of the next open trading window immediately following each of the third and fourth anniversaries of the grant date, provided that the Reporting Person remains in continuous service through each vest date. F3 · derivative.expiration_date: Restricted Stock Unit award was granted on April 6, 2017. 25% of the shares vested on May 11, 2018, 25% of the shares vested on May 10, 2019, with 25% more vesting on the first day of the next open trading window immediately following each of the third and fourth anniversaries of the grant date, provided that the Reporting Person remains in continuous service through each vest date. F3 · balance_after: Restricted Stock Unit award was granted on April 6, 2017. 25% of the shares vested on May 11, 2018, 25% of the shares vested on May 10, 2019, with 25% more vesting on the first day of the next open trading window immediately following each of the third and fourth anniversaries of the grant date, provided that the Reporting Person remains in continuous service through each vest date. Read SEC document |
| May 10, 2019 Filed May 14, 2019 19:51 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Tax withholdingCommon Stock, par value $0.0001 per share | 3,371 | $1.74 | $5,865.54 |
DisclosureSEC source: 0001550695-19-000042 · wf-form4_155787786917774.xml · nonDerivative · entry 4 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,753 F1 · shares: Shares surrendered to pay tax liability due on vesting of Restricted Stock Units Read SEC document |
| May 10, 2019 Filed May 14, 2019 19:51 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Exercise / conversionCommon Stock, par value $0.0001 per share | 14,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001550695-19-000042 · wf-form4_155787786917774.xml · nonDerivative · entry 3 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,124 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2019 Filed May 14, 2019 19:51 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Tax withholdingCommon Stock, par value $0.0001 per share | 5,337 | $1.74 | $9,286.38 |
DisclosureSEC source: 0001550695-19-000042 · wf-form4_155787786917774.xml · nonDerivative · entry 2 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,749 F1 · shares: Shares surrendered to pay tax liability due on vesting of Restricted Stock Units Read SEC document |
| May 10, 2019 Filed May 14, 2019 19:51 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Exercise / conversionCommon Stock, par value $0.0001 per share | 18,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001550695-19-000042 · wf-form4_155787786917774.xml · nonDerivative · entry 1 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2019 Filed May 6, 2019 20:44 UTC | Performant Healthcare Inc PFMT · Entity 74046 | GrantRestricted Stock Units · Derivative | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001550695-19-000028 · wf-form4_155718986061395.xml · derivative · entry 2 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to the Reporting Person. F3 · derivative.exercise_date: Restricted Stock Unit award was granted on May 2, 2019. The number of Restricted Stock Units reported represents the maximum of 200% of the target level for this Restricted Stock Unit award. These Restricted Stock Units shall vest over a nearly four year period based upon continuing service and the trading price of PFMT's Common Stock during the relevant vesting period. Specifically, and subject to the vesting limitations described in the following sentence, the trading price for PFMT's shares will need to be sustained for 60 consecutive trading days for one of the following vesting thresholds to have been met: (1) $2.75 per share stock price for 60 consecutive trading days triggers 12.5% vesting; (2) $3.00 per share stock price for 60 consecutive trading days triggers 25% vesting; (3) $3.25 per share stock price for 60 consecutive trading days triggers 37.5% vesting; (4) $3.50 per share stock price for 60 consecutive trading days triggers 50% vesting; F4 · derivative.exercise_date: (Continued from Footnote 3) (5) $3.75 per share stock price for 60 consecutive trading days triggers 66.5% vesting; (6) $4.00 per share stock price for 60 consecutive trading days triggers 83% vesting; and (7) $4.25 per share stock price for 60 consecutive trading days triggers 100% vesting (the "Share Price Thresholds"). On April 29 in each of 2020, 2021, 2022 and 2023 (each a "vesting date"), if the Share Price Thresholds have been achieved during the preceding year and assuming the Reporting Person's continued service to PFMT (1) up to a maximum of 25% of the Restricted Stock Units will vest upon the first vesting date; (2) up to a maximum of 50% of the Restricted Stock Units will vest upon the second vesting date; (3) up to a maximum of 75% of the Restricted Stock Units will vest upon the third vesting date; and (4) up to 100% of the Restricted Stock Units will vest upon the fourth vesting date. F5 · derivative.exercise_date: (Continued from Footnote 4) That portion of the Restricted Stock Units that would vest solely on the basis of the share price thresholds that exceeds the maximum vesting limitations for the first, second and third vesting dates will not vest until the subsequent vesting date or dates (e.g., if the $3.50 per share trading price threshold is attained prior to the first vesting date which would otherwise trigger 50% vesting, then 25% of Restricted Stock Units will vest as of the first vesting date, with the remaining 25% of the Restricted Stock Units to vest as of the second vesting date, subject to the vesting limitations as of such vesting date and continued service as of such vesting date). Linear interpolation will be applied between milestones for determining vesting on the third and fourth vesting dates. F3 · derivative.expiration_date: Restricted Stock Unit award was granted on May 2, 2019. The number of Restricted Stock Units reported represents the maximum of 200% of the target level for this Restricted Stock Unit award. These Restricted Stock Units shall vest over a nearly four year period based upon continuing service and the trading price of PFMT's Common Stock during the relevant vesting period. Specifically, and subject to the vesting limitations described in the following sentence, the trading price for PFMT's shares will need to be sustained for 60 consecutive trading days for one of the following vesting thresholds to have been met: (1) $2.75 per share stock price for 60 consecutive trading days triggers 12.5% vesting; (2) $3.00 per share stock price for 60 consecutive trading days triggers 25% vesting; (3) $3.25 per share stock price for 60 consecutive trading days triggers 37.5% vesting; (4) $3.50 per share stock price for 60 consecutive trading days triggers 50% vesting; F4 · derivative.expiration_date: (Continued from Footnote 3) (5) $3.75 per share stock price for 60 consecutive trading days triggers 66.5% vesting; (6) $4.00 per share stock price for 60 consecutive trading days triggers 83% vesting; and (7) $4.25 per share stock price for 60 consecutive trading days triggers 100% vesting (the "Share Price Thresholds"). On April 29 in each of 2020, 2021, 2022 and 2023 (each a "vesting date"), if the Share Price Thresholds have been achieved during the preceding year and assuming the Reporting Person's continued service to PFMT (1) up to a maximum of 25% of the Restricted Stock Units will vest upon the first vesting date; (2) up to a maximum of 50% of the Restricted Stock Units will vest upon the second vesting date; (3) up to a maximum of 75% of the Restricted Stock Units will vest upon the third vesting date; and (4) up to 100% of the Restricted Stock Units will vest upon the fourth vesting date. F5 · derivative.expiration_date: (Continued from Footnote 4) That portion of the Restricted Stock Units that would vest solely on the basis of the share price thresholds that exceeds the maximum vesting limitations for the first, second and third vesting dates will not vest until the subsequent vesting date or dates (e.g., if the $3.50 per share trading price threshold is attained prior to the first vesting date which would otherwise trigger 50% vesting, then 25% of Restricted Stock Units will vest as of the first vesting date, with the remaining 25% of the Restricted Stock Units to vest as of the second vesting date, subject to the vesting limitations as of such vesting date and continued service as of such vesting date). Linear interpolation will be applied between milestones for determining vesting on the third and fourth vesting dates. F3 · balance_after: Restricted Stock Unit award was granted on May 2, 2019. The number of Restricted Stock Units reported represents the maximum of 200% of the target level for this Restricted Stock Unit award. These Restricted Stock Units shall vest over a nearly four year period based upon continuing service and the trading price of PFMT's Common Stock during the relevant vesting period. Specifically, and subject to the vesting limitations described in the following sentence, the trading price for PFMT's shares will need to be sustained for 60 consecutive trading days for one of the following vesting thresholds to have been met: (1) $2.75 per share stock price for 60 consecutive trading days triggers 12.5% vesting; (2) $3.00 per share stock price for 60 consecutive trading days triggers 25% vesting; (3) $3.25 per share stock price for 60 consecutive trading days triggers 37.5% vesting; (4) $3.50 per share stock price for 60 consecutive trading days triggers 50% vesting; F4 · balance_after: (Continued from Footnote 3) (5) $3.75 per share stock price for 60 consecutive trading days triggers 66.5% vesting; (6) $4.00 per share stock price for 60 consecutive trading days triggers 83% vesting; and (7) $4.25 per share stock price for 60 consecutive trading days triggers 100% vesting (the "Share Price Thresholds"). On April 29 in each of 2020, 2021, 2022 and 2023 (each a "vesting date"), if the Share Price Thresholds have been achieved during the preceding year and assuming the Reporting Person's continued service to PFMT (1) up to a maximum of 25% of the Restricted Stock Units will vest upon the first vesting date; (2) up to a maximum of 50% of the Restricted Stock Units will vest upon the second vesting date; (3) up to a maximum of 75% of the Restricted Stock Units will vest upon the third vesting date; and (4) up to 100% of the Restricted Stock Units will vest upon the fourth vesting date. F5 · balance_after: (Continued from Footnote 4) That portion of the Restricted Stock Units that would vest solely on the basis of the share price thresholds that exceeds the maximum vesting limitations for the first, second and third vesting dates will not vest until the subsequent vesting date or dates (e.g., if the $3.50 per share trading price threshold is attained prior to the first vesting date which would otherwise trigger 50% vesting, then 25% of Restricted Stock Units will vest as of the first vesting date, with the remaining 25% of the Restricted Stock Units to vest as of the second vesting date, subject to the vesting limitations as of such vesting date and continued service as of such vesting date). Linear interpolation will be applied between milestones for determining vesting on the third and fourth vesting dates. Read SEC document |
| May 02, 2019 Filed May 6, 2019 20:44 UTC | Performant Healthcare Inc PFMT · Entity 74046 | GrantRestricted Stock Units · Derivative | 45,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001550695-19-000028 · wf-form4_155718986061395.xml · derivative · entry 1 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to the Reporting Person. F1 · price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to the Reporting Person. F2 · derivative.exercise_date: Restricted Stock Unit award was granted on May 2, 2019. The restricted stock unit award vests at a rate of 25% annually on the first, second, third and fourth anniversaries of April 29, 2019, provided that the Reporting Person remains in continuous service through each vest date. F2 · derivative.expiration_date: Restricted Stock Unit award was granted on May 2, 2019. The restricted stock unit award vests at a rate of 25% annually on the first, second, third and fourth anniversaries of April 29, 2019, provided that the Reporting Person remains in continuous service through each vest date. F2 · balance_after: Restricted Stock Unit award was granted on May 2, 2019. The restricted stock unit award vests at a rate of 25% annually on the first, second, third and fourth anniversaries of April 29, 2019, provided that the Reporting Person remains in continuous service through each vest date. Read SEC document |
| March 07, 2019 Filed Mar 11, 2019 21:33 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Exercise / conversionRestricted Stock Units · Derivative | 11,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001550695-19-000012 · wf-form4_155235437257219.xml · derivative · entry 3 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to the Reporting Person. F2 · price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to the Reporting Person. F3 · derivative.exercise_date: Restricted Stock Unit award was granted on 02/22/16. 25% of the shares vested on March 7, 2017, 25% of the shares vested on March 7, 2018, and 25% of the shares vested on March 7, 2019 with 25% more vesting on the third anniversary of the initial vest date, provided that the Reporting Person remains in continuous service through each vest date. F3 · derivative.expiration_date: Restricted Stock Unit award was granted on 02/22/16. 25% of the shares vested on March 7, 2017, 25% of the shares vested on March 7, 2018, and 25% of the shares vested on March 7, 2019 with 25% more vesting on the third anniversary of the initial vest date, provided that the Reporting Person remains in continuous service through each vest date. Read SEC document |
| March 07, 2019 Filed Mar 11, 2019 21:33 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Tax withholdingCommon Stock, par value $0.0001 per share | 3,336 | $2.10 | $7,005.60 |
DisclosureSEC source: 0001550695-19-000012 · wf-form4_155235437257219.xml · nonDerivative · entry 2 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,336 F1 · shares: Shares surrendered to pay tax liability due on vesting of Restricted Stock Units Read SEC document |
| March 07, 2019 Filed Mar 11, 2019 21:33 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Exercise / conversionCommon Stock, par value $0.0001 per share | 11,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001550695-19-000012 · wf-form4_155235437257219.xml · nonDerivative · entry 1 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,672 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2019 Filed Feb 15, 2019 18:26 UTC | Performant Healthcare Inc PFMT · Entity 74046 | SaleCommon Stock, par value $0.0001 per share | 2,915 | $2.20 | $6,413.00 |
DisclosureSEC source: 0001550695-19-000010 · wf-form4_155027317761623.xml · nonDerivative · entry 2 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,422 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 trading plan established on June 8, 2018. This Rule 10b5-1 trading plan terminated on February 15, 2019. Read SEC document |
| February 14, 2019 Filed Feb 15, 2019 18:26 UTC | Performant Healthcare Inc PFMT · Entity 74046 | SaleCommon Stock, par value $0.0001 per share | 1,450 | $2.20 | $3,190.00 |
DisclosureSEC source: 0001550695-19-000010 · wf-form4_155027317761623.xml · nonDerivative · entry 1 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,337 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 trading plan established on June 8, 2018. This Rule 10b5-1 trading plan terminated on February 15, 2019. Read SEC document |
| February 13, 2019 Filed Feb 14, 2019 17:34 UTC | Performant Healthcare Inc PFMT · Entity 74046 | SaleCommon Stock, par value $0.0001 per share | 1,012 | $2.20 | $2,226.40 |
DisclosureSEC source: 0001550695-19-000008 · wf-form4_155018364476162.xml · nonDerivative · entry 2 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,787 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 trading plan established on June 8, 2018. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 17:34 UTC | Performant Healthcare Inc PFMT · Entity 74046 | SaleCommon Stock, par value $0.0001 per share | 414 | $2.20 | $910.80 |
DisclosureSEC source: 0001550695-19-000008 · wf-form4_155018364476162.xml · nonDerivative · entry 1 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,799 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 trading plan established on June 8, 2018. Read SEC document |
| February 11, 2019 Filed Feb 12, 2019 17:36 UTC | Performant Healthcare Inc PFMT · Entity 74046 | SaleCommon Stock, par value $0.0001 per share | 101 | $2.20 | $222.20 |
DisclosureSEC source: 0001550695-19-000006 · wf-form4_155001099536242.xml · nonDerivative · entry 2 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,213 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 trading plan established on June 8, 2018. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 17:36 UTC | Performant Healthcare Inc PFMT · Entity 74046 | SaleCommon Stock, par value $0.0001 per share | 2,842 | $2.20 | $6,252.40 |
DisclosureSEC source: 0001550695-19-000006 · wf-form4_155001099536242.xml · nonDerivative · entry 1 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,314 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 trading plan established on June 8, 2018. Read SEC document |
| February 07, 2019 Filed Feb 8, 2019 18:05 UTC | Performant Healthcare Inc PFMT · Entity 74046 | SaleCommon Stock, par value $0.0001 per share | 9 | $2.20 | $19.80 |
DisclosureSEC source: 0001550695-19-000004 · wf-form4_154966707681313.xml · nonDerivative · entry 2 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,156 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 trading plan established on June 8, 2018. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 18:05 UTC | Performant Healthcare Inc PFMT · Entity 74046 | SaleCommon Stock, par value $0.0001 per share | 299 | $2.20 | $657.80 |
DisclosureSEC source: 0001550695-19-000004 · wf-form4_154966707681313.xml · nonDerivative · entry 1 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,165 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 trading plan established on June 8, 2018. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 14:36 UTC | Performant Healthcare Inc PFMT · Entity 74046 | SaleCommon Stock, par value $0.0001 per share | 4,052 | $2.20 | $8,914.40 |
DisclosureSEC source: 0001550695-19-000002 · wf-form4_154939536590183.xml · nonDerivative · entry 2 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,464 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 trading plan established on June 8, 2018. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 14:36 UTC | Performant Healthcare Inc PFMT · Entity 74046 | SaleCommon Stock, par value $0.0001 per share | 1,706 | $2.20 | $3,753.20 |
DisclosureSEC source: 0001550695-19-000002 · wf-form4_154939536590183.xml · nonDerivative · entry 1 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,516 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 trading plan established on June 8, 2018. Read SEC document |
| September 27, 2018 Filed Oct 1, 2018 19:03 UTC | Performant Healthcare Inc PFMT · Entity 74046 | SaleCommon Stock, par value $0.0001 per share | 200 | $2.20 | $440.00 |
DisclosureSEC source: 0001550695-18-000047 · wf-form4_153843496738806.xml · nonDerivative · entry 1 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,222 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 trading plan established on June 8, 2018. Read SEC document |
| August 27, 2018 Filed Aug 28, 2018 16:18 UTC | Performant Healthcare Inc PFMT · Entity 74046 | SaleCommon Stock, par value $0.0001 per share | 1,458 | $2.20 | $3,207.60 |
DisclosureSEC source: 0001550695-18-000043 · wf-form4_153548747087205.xml · nonDerivative · entry 1 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,422 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 trading plan established on June 8, 2018. Read SEC document |
| August 24, 2018 Filed Aug 27, 2018 19:17 UTC | Performant Healthcare Inc PFMT · Entity 74046 | SaleCommon Stock, par value $0.0001 per share | 1,034 | $2.20 | $2,274.80 |
DisclosureSEC source: 0001550695-18-000041 · wf-form4_153541181096091.xml · nonDerivative · entry 1 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,880 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 trading plan established on June 8, 2018. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 19:12 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Exercise / conversionRestricted Stock Units · Derivative | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001550695-18-000038 · wf-form4_153437471376711.xml · derivative · entry 3 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to Reporting Person. F2 · price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to Reporting Person. F3 · derivative.exercise_date: Restricted Stock Unit award was granted on 08/13/2014 and expires on 08/13/2024. The restricted stock unit award vests at a rate of 25% annually on the first, second, third and fourth anniversaries of the grant date, provided that the Reporting Person remains in continuous service through each vest date. F3 · derivative.expiration_date: Restricted Stock Unit award was granted on 08/13/2014 and expires on 08/13/2024. The restricted stock unit award vests at a rate of 25% annually on the first, second, third and fourth anniversaries of the grant date, provided that the Reporting Person remains in continuous service through each vest date. F3 · balance_after: Restricted Stock Unit award was granted on 08/13/2014 and expires on 08/13/2024. The restricted stock unit award vests at a rate of 25% annually on the first, second, third and fourth anniversaries of the grant date, provided that the Reporting Person remains in continuous service through each vest date. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 19:12 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Tax withholdingCommon Stock, par value $0.0001 per share | 761 | $2.11 | $1,605.71 |
DisclosureSEC source: 0001550695-18-000038 · wf-form4_153437471376711.xml · nonDerivative · entry 2 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,914 F1 · shares: Shares surrendered to pay tax liability due on vesting of Restricted Stock Units. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 19:12 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Exercise / conversionCommon Stock, par value $0.0001 per share | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001550695-18-000038 · wf-form4_153437471376711.xml · nonDerivative · entry 1 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,675 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2018 Filed Aug 13, 2018 18:50 UTC | Performant Healthcare Inc PFMT · Entity 74046 | SaleCommon Stock, par value $0.0001 per share | 508 | $2.20 | $1,117.60 |
DisclosureSEC source: 0001550695-18-000032 · wf-form4_153420060777183.xml · nonDerivative · entry 1 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,550 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 trading plan established on June 8, 2018. Read SEC document |
| July 10, 2018 Filed Jul 11, 2018 19:58 UTC | Performant Healthcare Inc PFMT · Entity 74046 | SaleCommon Stock, par value $0.0001 per share | 1,695 | $2.20 | $3,729.00 |
DisclosureSEC source: 0001550695-18-000022 · wf-form4_153135351772992.xml · nonDerivative · entry 2 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,058 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 trading plan established on June 8, 2018. Read SEC document |
| July 09, 2018 Filed Jul 11, 2018 19:58 UTC | Performant Healthcare Inc PFMT · Entity 74046 | SaleCommon Stock, par value $0.0001 per share | 1,305 | $2.20 | $2,871.00 |
DisclosureSEC source: 0001550695-18-000022 · wf-form4_153135351772992.xml · nonDerivative · entry 1 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,753 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 trading plan established on June 8, 2018. Read SEC document |
| May 11, 2018 Filed May 15, 2018 20:53 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Exercise / conversionRestricted Stock Units · Derivative | 18,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-013021 · doc4.xml · derivative · entry 3 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,250 Underlying: Common Stock · 18,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to the Reporting Person. F2 · price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to the Reporting Person. F3 · derivative.exercise_date: Restricted Stock Unit award was granted on 04/06/17. 25% of the shares vested on May 11, 2018, with 25% more vesting on the first day of the next open trading window immediately following each of the second, third and fourth anniversaries of the grant date, provided that the Reporting Person remains in continuous service through each vest date. F3 · derivative.expiration_date: Restricted Stock Unit award was granted on 04/06/17. 25% of the shares vested on May 11, 2018, with 25% more vesting on the first day of the next open trading window immediately following each of the second, third and fourth anniversaries of the grant date, provided that the Reporting Person remains in continuous service through each vest date. F3 · balance_after: Restricted Stock Unit award was granted on 04/06/17. 25% of the shares vested on May 11, 2018, with 25% more vesting on the first day of the next open trading window immediately following each of the second, third and fourth anniversaries of the grant date, provided that the Reporting Person remains in continuous service through each vest date. Read SEC document |
| May 11, 2018 Filed May 15, 2018 20:53 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Tax withholdingCommon Stock, par value $0.0001 per share | 4,397 | $2.91 | $12,795.27 |
DisclosureSEC source: 0000899243-18-013021 · doc4.xml · nonDerivative · entry 2 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,058 F1 · shares: Shares surrendered to pay tax liability due on vesting of Restricted Stock Units. Read SEC document |
| May 11, 2018 Filed May 15, 2018 20:53 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Exercise / conversionCommon Stock, par value $0.0001 per share | 18,750 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-013021 · doc4.xml · nonDerivative · entry 1 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 20:22 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Exercise / conversionRestricted Stock Units · Derivative | 57,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-009132 · doc4.xml · derivative · entry 1 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,500 Underlying: Common Stock · 57,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to the Reporting Person. F1 · price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to the Reporting Person. F2 · derivative.exercise_date: Restricted Stock Unit award was granted on 03/29/18. The restricted stock unit award vests at a rate of 25% annually on the first, second, third and fourth anniversaries of the grants date, provided that the Reporting Person remains in continuous service through each vest date. F2 · derivative.expiration_date: Restricted Stock Unit award was granted on 03/29/18. The restricted stock unit award vests at a rate of 25% annually on the first, second, third and fourth anniversaries of the grants date, provided that the Reporting Person remains in continuous service through each vest date. F2 · balance_after: Restricted Stock Unit award was granted on 03/29/18. The restricted stock unit award vests at a rate of 25% annually on the first, second, third and fourth anniversaries of the grants date, provided that the Reporting Person remains in continuous service through each vest date. Read SEC document |
| March 07, 2018 Filed Mar 9, 2018 21:18 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Exercise / conversionRestricted Stock Units · Derivative | 11,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-007009 · doc4.xml · derivative · entry 3 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 11,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to the Reporting Person. F2 · price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to the Reporting Person. F3 · derivative.exercise_date: Restricted Stock Unit award was granted on 02/22/16. 25% of the shares vested on March 7, 2017 and 25% of the shares vested on March 7, 2018, with 25% more vesting on each of the second and third anniversaries of the initial vest date, provided that the Reporting Person remains in continuous service through each vest date. F3 · derivative.expiration_date: Restricted Stock Unit award was granted on 02/22/16. 25% of the shares vested on March 7, 2017 and 25% of the shares vested on March 7, 2018, with 25% more vesting on each of the second and third anniversaries of the initial vest date, provided that the Reporting Person remains in continuous service through each vest date. F3 · balance_after: Restricted Stock Unit award was granted on 02/22/16. 25% of the shares vested on March 7, 2017 and 25% of the shares vested on March 7, 2018, with 25% more vesting on each of the second and third anniversaries of the initial vest date, provided that the Reporting Person remains in continuous service through each vest date. Read SEC document |
| March 07, 2018 Filed Mar 9, 2018 21:18 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Tax withholdingCommon Stock, par value $0.0001 per share | 2,690 | $2.86 | $7,693.40 |
DisclosureSEC source: 0000899243-18-007009 · doc4.xml · nonDerivative · entry 2 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,705 F1 · shares: Shares surrendered to pay tax liability due on vesting of Restricted Stock Units. Read SEC document |
| March 07, 2018 Filed Mar 9, 2018 21:18 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Exercise / conversionCommon Stock, par value $0.0001 per share | 11,250 | $2.86 | $32,175.00 |
DisclosureSEC source: 0000899243-18-007009 · doc4.xml · nonDerivative · entry 1 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,395 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 21:40 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Exercise / conversionPerformance Stock Units · Derivative | 5,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-18-006771 · doc4.xml · derivative · entry 3 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to the Reporting Person. F2 · price: Each performance stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to the Reporting Person. F3 · derivative.exercise_date: Performance Stock Unit award was granted on 03/17/15. The performance stock award vested as to 50% of the covered shares on March 5, 2016, as to 25% of the covered shares on March 5, 2017, and as to 25% of the covered shares on March 5, 2018. F3 · derivative.expiration_date: Performance Stock Unit award was granted on 03/17/15. The performance stock award vested as to 50% of the covered shares on March 5, 2016, as to 25% of the covered shares on March 5, 2017, and as to 25% of the covered shares on March 5, 2018. F3 · balance_after: Performance Stock Unit award was granted on 03/17/15. The performance stock award vested as to 50% of the covered shares on March 5, 2016, as to 25% of the covered shares on March 5, 2017, and as to 25% of the covered shares on March 5, 2018. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 21:40 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Tax withholdingCommon Stock, par value $0.0001 per share | 2,351 | $2.65 | $6,230.15 |
DisclosureSEC source: 0000899243-18-006771 · doc4.xml · nonDerivative · entry 2 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,145 F1 · shares: Shares surrendered to pay tax liability due on vesting of Performance Stock Units. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 21:40 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Exercise / conversionCommon Stock, par value $0.0001 per share | 5,750 | $2.65 | $15,237.50 |
DisclosureSEC source: 0000899243-18-006771 · doc4.xml · nonDerivative · entry 1 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,496 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 13, 2017 Filed Aug 15, 2017 20:37 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Exercise / conversionRestricted Stock Units · Derivative | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-020404 · doc4.xml · derivative · entry 3 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,125 Underlying: Common Stock · 3,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to Reporting Person. F3 · derivative.exercise_date: Restricted Stock Unit award was granted on 08/13/2014 and expires on 08/13/2024. The restricted stock unit award vests at a rate of 25% annually on the first, second, third and fourth anniversaries of the grant date, provided that the Reporting Person remains in continuous service through each vest date. F3 · derivative.expiration_date: Restricted Stock Unit award was granted on 08/13/2014 and expires on 08/13/2024. The restricted stock unit award vests at a rate of 25% annually on the first, second, third and fourth anniversaries of the grant date, provided that the Reporting Person remains in continuous service through each vest date. F3 · balance_after: Restricted Stock Unit award was granted on 08/13/2014 and expires on 08/13/2024. The restricted stock unit award vests at a rate of 25% annually on the first, second, third and fourth anniversaries of the grant date, provided that the Reporting Person remains in continuous service through each vest date. Read SEC document |
| August 13, 2017 Filed Aug 15, 2017 20:37 UTC | Performant Healthcare Inc PFMT · Entity 74046 | Tax withholdingCommon Stock, par value $0.0001 per share | 827 | $1.85 | $1,529.95 |
DisclosureSEC source: 0000899243-17-020404 · doc4.xml · nonDerivative · entry 2 Kohl Simeon · CIK 0001703807 · Vice President of Healthcare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,746 F1 · shares: Shares surrendered to pay tax liability due on vesting of Restricted Stock Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.